The NASA Task Book
Advanced Search     

Project Title:  Tempus ALS ISS Technology Demonstration Reduce
Images: icon  Fiscal Year: FY 2022 
Division: Human Research 
Research Discipline/Element:
HRP ExMC:Exploration Medical Capabilities
Start Date: 08/08/2022  
End Date: 09/30/2024  
Task Last Updated: 12/12/2022 
Download report in PDF pdf
Principal Investigator/Affiliation:   Lewandowski, Beth  Ph.D. / NASA Glenn Research Center 
Address:  Bioscience and Technology Branch 
Cleveland , OH 44135 
Phone: 216-433-8873  
Congressional District:
Organization Type: NASA CENTER 
Organization Name: NASA Glenn Research Center 
Joint Agency:  
Lehnhardt, Kris  M.D. NASA Johnson Space Center  
Easter, Benjamin  M.D. NASA Johnson Space Center 
Suresh, Rahul  M.D. NASA Johnson Space Center 
Thompson, Moriah  M.D. NASA Johnson Space Center 
Project Information: Grant/Contract No. Directed Research 
Responsible Center: NASA JSC 
Grant Monitor: Lehnhardt, Kris  
Center Contact: 281.244.0524 
Unique ID: 15256 
Solicitation / Funding Source: Directed Research 
Grant/Contract No.: Directed Research 
Project Type: FLIGHT 
Flight Program:  
TechPort: No 
No. of Post Docs:  
No. of PhD Candidates:  
No. of Master's Candidates:  
No. of Bachelor's Candidates:  
No. of PhD Degrees:  
No. of Master's Degrees:  
No. of Bachelor's Degrees:  
Human Research Program Elements: (1) ExMC:Exploration Medical Capabilities
Human Research Program Risks: (1) Medical Conditions:Risk of Adverse Health Outcomes and Decrements in Performance Due to Medical Conditions that occur in Mission, as well as Long Term Health Outcomes Due to Mission Exposures (IRP Rev M)
Human Research Program Gaps: (1) Medical-701:We need to increase inflight medical capabilities and identify new capabilities that (a) maximize benefit and/or (b) reduce “costs” on human system/mission/vehicle resources (IRP Rev L)
Task Description: The aim of this project is to evaluate the use of the Tempus Advanced Life Support (ALS) device in the spaceflight environment:

• In collaboration with the European Space Agency (ESA), Phase 1 entails using the Tempus ALS device, compared to current International Space Station (ISS) medical devices, for the completion of Periodic Health Status exams and ISS medical contingency drills for 6 crewmembers (ESA = 2, NASA = 4), in order to achieve ESA’s test objectives as described in the ESA Tempus ALS Technology Demonstration Activity Requirements Document (ARD)1.

• NASA-led Phase 2 of the demonstration will entail Exploration Medical Capability (ExMC) and the Exploration Medical Integrated Product Team (XMIPT) working together to demonstrate the use of Tempus ALS on the ISS as part of progressively Earth-Independent Medical Operations (EIMO) through the execution of onboard medical simulations that emphasize crew autonomy during exploration medical care.

The Tempus ALS is a multifunctional medical device with capabilities that include vital sign collection and monitoring, communications to enable telemedicine, interfaces with electronic health records, ultrasound, video laryngoscopy, and defibrillation. Tempus for ISS project activities will include evaluation of the usability of the Tempus ALS in a spaceflight environment, its functionality during the diagnosis and treatment of simulated medical conditions, and the increased onboard capabilities that it can provide when operated autonomously. The project results will be used to answer the question: Is the Tempus ALS a good candidate for inclusion within spaceflight medical system operations on exploration missions?

For this project, simulations of one or more medical contingency scenarios will be executed and ISS astronauts will be required to follow and perform the NASA and ESA developed medical procedures necessary for diagnosing and treating the medical emergency. The astronauts will be required to use several of the capabilities of the Tempus ALS device while performing these procedures. The astronauts will perform the procedures under varying levels of autonomy, including with and without communication delays and with different types of procedural guidance.

Rationale for HRP Directed Research: This research is directed because it contains highly constrained research. Currently aboard the International Space Station (ISS), NASA has the ability to perform in-flight medical vital signs monitoring, in-flight imaging, and Periodic Health Status exams with a suite of medical devices and techniques. On the ISS, these medical procedures are currently accomplished with reliance on the Flight and Medical Operations teams on the ground.

For long-duration space missions, mass, power, and volume requirements for medical devices will be increasingly limited. Further, with increased distance, the Earth-Independent Medical Operations (EIMO) capability will be a cornerstone of the provision of adequate medical care during exploration missions beyond low-Earth orbit (BLEO). There is a need to identify and evaluate medical devices that will be amenable to the EIMO construct.

Research Impact/Earth Benefits:

Task Progress & Bibliography Information FY2022 
Task Progress: New project for FY2022.

Bibliography: Description: (Last Updated: 03/01/2018) 

Show Cumulative Bibliography
 None in FY 2022